Feasibility studies, clinical trial readiness, GMP/clinical trial materials
Ended Awarded Last action
- Contract number
- 75N95022F00001
- Awardee
-
Curia Global Inc. UEI ELCNZCS8GEA3
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,135,800
Award facts
- Contract value 100% obligated
- $1,135,799.54 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Albany, NY 12203, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Terminate for Convenience | $0 | |
| Funding Only Action | $89,686 | |
| Original award | $1,046,113 |
About this award
This is a delivery order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Curia Global Inc. (doing business as Amri), a for-profit manufacturer. The contract is part of the larger Drug Manufacturing and Formulation Program (DMFP) Indefinite Delivery, Indefinite Quantity (IDIQ) master contract vehicle. The award is for $1,135,799.54 and covers feasibility studies, clinical trial readiness activities, and good manufacturing practice (GMP)/clinical trial materials production. The contract has no set-aside designation, indicating Curia Global competes effectively as a large business contractor. Curia Global has demonstrated expertise in specialized pharmaceutical research and development services for federal agencies, including the National Institutes of Health (NIH) ecosystem.
Quick answers
Who was awarded contract 75N95022F00001?
75N95022F00001 was awarded to Curia Global Inc. by National Institute on Drug Abuse (National Institutes of Health) on July 6, 2022.
How much is contract 75N95022F00001 worth?
The government has obligated $1,135,800 on 75N95022F00001.
Is contract 75N95022F00001 an order under another contract?
Yes. 75N95022F00001 is a delivery order under HHSN271201500005I, an indefinite delivery contract, on Drug Manufacturing and Formulation Program (DMFP).
Was contract 75N95022F00001 competed?
The extent of competition for 75N95022F00001 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award